1.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BIOS-012010, NCT01374373
|
|
2.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR005143, EPOANE3010, 2005-001817-17, NCT00338286
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: ECOG-E2905, E2905, NCT00843882
|
|
4.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR018367, EPOANE3021, 2010-022884-36, NCT01381809
|
|
5.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 40 to 59
Sponsor: Other
Protocol IDs: NA_00010941, NCT00737893
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLBH589BDE04, EudraCT 2009-010403-84, NCT01034657
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NMDSG08A, 2009-011483-11, NCT01048034
|
|
8.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: SMD-TXAGO, NCT01356875
|
Mobile | Español
